Cramer Remix: This is something Bristol-Myers should do
March 06, 2019 at 20:52 PM EST
Jim Cramer reveals what he thinks about Bristol-Myers' bid to buy Celgene.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.